A Phase I Trial of Lenalidomide in Patients With Recurrent Primary Central Nervous System Tumors

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-07-1546
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)